How Peptides Work: Mechanisms of Action by Class

Peptides are signalling molecules, not nutrients. What they do depends almost entirely on which receptor they bind and how long they survive in the bloodstream. This chapter walks through the mechanisms behind the main peptide classes covered in this guide.

Peptides are signalling molecules, not nutrients. What they do depends almost entirely on which receptor they bind and how long they survive in the bloodstream. This chapter walks through the mechanisms behind the main peptide classes covered in this guide.

How Semaglutide Works: Mechanism of Action Explained

Mechanism of Action

Semaglutide functions by mimicking the action of the naturally occurring hormone GLP-1. It binds to GLP-1 receptors, primarily found on pancreatic beta cells, leading to enhanced insulin secretion in a glucose-dependent manner. This mechanism helps to lower blood glucose levels effectively. Additionally, semaglutide suppresses glucagon release, which reduces hepatic glucose production. The peptide also slows gastric emptying, contributing to reduced appetite and subsequent weight loss (PMID: 26308095).

How It Compares to Similar Peptides

Compared to other GLP-1 receptor agonists, such as liraglutide , semaglutide offers the advantage of less frequent dosing due to its longer half-life. Tirzepatide , another peptide under development, acts as a dual agonist for both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, potentially offering a broader metabolic effect, but semaglutide remains a selective GLP-1 agonist (PMID: 34170647).

How does semaglutide cause pancreatitis?

The exact mechanism is not fully understood, but it is hypothesized that changes in pancreatic enzyme activity or direct effects on pancreatic cells may contribute.

How long does it take for semaglutide to work?

Patients may notice improvements in blood sugar levels within the first week, with weight loss becoming more apparent over several weeks.

How Sermorelin Works: Mechanism of Action Explained

Sermorelin, a 29-amino acid peptide, mimics the natural GHRH , binding to specific receptors on the pituitary gland. This binding activates the cAMP (cyclic adenosine monophosphate) signaling pathway, which in turn stimulates the synthesis and secretion of growth hormone (GH) from the anterior pituitary (PMID 18046908). The increase in circulating GH levels leads to downstream effects such as protein synthesis, lipolysis, and glucose metabolism modulation.

Compared to other GHRH analogs like CJC-1295 or Ipamorelin , Sermorelin has a shorter duration of action, which may require more frequent dosing. CJC-1295 , for instance, has a longer half-life due to its ability to bind to serum albumin, offering prolonged GH release. Providers may choose Sermorelin for patients who prefer shorter-acting treatments or have specific dosing needs.

How BPC-157 Works: Mechanism of Action Explained

How Does BPC-157 Work? Mechanism of Action Explained

BPC-157 ( Body Protection Compound -157) works primarily by promoting angiogenesis, modulating nitric oxide synthesis, activating growth hormone receptors locally, and exerting anti-inflammatory effects at tissue injury sites. It is a 15-amino acid peptide derived from human gastric juice.

BPC-157 Mechanism of Action Summary

BPC-157 does not work through a single mechanism — it acts on multiple pathways simultaneously:

2. Nitric Oxide Pathway

BPC-157 both modulates nitric oxide production and partially works through NO-independent pathways. Nitric oxide promotes vasodilation and blood flow, contributing to enhanced delivery of healing factors to injured tissue.

3. Growth Hormone Receptor Interaction

Unlike sermorelin or CJC-1295 , BPC-157 does not stimulate systemic growth hormone release. Instead, it appears to modulate growth hormone receptor sensitivity locally at injury sites, amplifying the tissue-specific effects of existing GH without systemic GH elevation.

Human Evidence for BPC-157 Mechanism

The overwhelming majority of mechanistic data comes from animal studies (primarily rodent models). BPC-157 has not completed large-scale human Phase III trials validating these mechanisms in humans, though:

• Small Phase I/II trials suggest tolerability and some biological activity
• The mechanistic pathways (VEGF, NO) are well-established in human biology; whether BPC-157 activates them equivalently in humans is the open question
• Anecdotal reports from clinical use are broadly consistent with the animal findings

How long does BPC-157 take to work?

In animal studies, measurable effects on tissue healing appear within 1–2 weeks of consistent administration. Clinical users typically report initial effects (reduced pain, improved function) within 2–4 weeks, with more significant healing in 6–12 weeks.

How GHK-Cu Works: Mechanism of Action Explained

GHK-Cu operates through copper-mediated redox mechanisms that regulate collagen production, gene expression, and enzymatic antioxidant pathways. The peptide binds to copper ions, forming a stable complex that can interact with various cellular signaling pathways. This interaction enhances the synthesis of collagen and glycosaminoglycans while modulating the activity of metalloproteinases and their inhibitors (PMID 26236730). GHK-Cu also influences gene expression, promoting wound healing and tissue regeneration (PMID 29986520).

Compared to other peptides like Matrixyl or Argireline , GHK-Cu’s unique mechanism involving copper ions provides distinct advantages in tissue regeneration and anti-inflammatory effects. While Matrixyl focuses on stimulating collagen synthesis through different pathways, GHK-Cu’s copper-mediated actions offer a broader range of cellular benefits. Providers might choose GHK-Cu for its comprehensive impact on skin health and wound healing.

How PT-141 Works: Mechanism of Action Explained

PT-141 functions as an agonist at melanocortin receptors, specifically MC3R and MC4R, which are predominantly located in the central nervous system. Its mechanism involves binding to these receptors, which are known to play a role in sexual arousal and energy homeostasis. Activation of these receptors by PT-141 leads to increased neuronal activity in the hypothalamus, a region critical for sexual function (PMID 12851303).

The binding of PT-141 to MC3R and MC4R initiates a signaling cascade involving the activation of adenylate cyclase and increased cyclic AMP (cAMP) levels. This cascade results in the activation of downstream pathways that enhance sexual arousal and desire. Notably, PT-141 does not act directly on the vascular system, unlike phosphodiesterase type 5 (PDE5) inhibitors, which are commonly used for erectile dysfunction (PMID 15134289).

PT-141 is often compared to other sexual wellness treatments such as PDE5 inhibitors, like sildenafil (Viagra). While PDE5 inhibitors work by enhancing blood flow to the genitals, PT-141 operates centrally, affecting sexual desire and arousal through neurochemical pathways. This central mechanism can be advantageous for individuals where psychological or neurochemical factors play a significant role in sexual dysfunction.

How does PT-141 differ from Viagra?

PT-141 targets the central nervous system to enhance sexual desire, while Viagra works by increasing blood flow to the genitals.

How quickly does PT-141 take effect?

Effects of PT-141 typically appear within 30 to 60 minutes after subcutaneous injection.

This article is part of the Peptide Therapy Complete Guide

• Chapter 1. What Is Peptide Therapy? A Plain-English Foundation
• Chapter 2. How Peptides Work: Mechanisms of Action by Class (you are here)
• Chapter 3. Is Peptide Therapy Safe? Side Effects, Interactions and Long-Term Data
• Chapter 4. The Legal and Regulatory Landscape for Peptides in the United States
• Chapter 5. FDA Compounding Decisions and the 2026 Peptide Rulemaking
• Chapter 6. Dosing Principles: How Peptide Protocols Are Actually Built
• Chapter 7. Side Effects Across Peptides: Patterns, Routes and Management
• Chapter 8. What Results to Expect, and When
• Chapter 9. Cost, Insurance and Access: What Peptide Therapy Actually Costs
• Chapter 10. Reconstitution, Administration and Handling
• Chapter 11. How to Choose a Peptide Therapy Clinic
• Chapter 12. Telehealth Peptide Therapy: How Remote Access Works
• Chapter 13. Clinical Protocols and Stacks
• Chapter 14. Weight Loss and Metabolic Peptides: Monographs
• Chapter 15. Growth Hormone and Performance Peptides: Monographs
• Chapter 16. Tissue Repair and Healing Peptides: Monographs
• Chapter 17. Longevity and Anti-Aging Peptides: Monographs
• Chapter 18. Cognitive, Mood and Sleep Peptides: Monographs
• Chapter 19. Skin, Hair and Aesthetic Peptides: Monographs
• Chapter 20. Sexual Health and Hormone Peptides: Monographs
• Chapter 21. Immune and Inflammatory Peptides: Monographs
• Chapter 22. Industry, Market and Research Developments

Previous: Chapter 1. What Is Peptide Therapy? A Plain-English Foundation

Next: Chapter 3. Is Peptide Therapy Safe? Side Effects, Interactions and Long-Term Data